Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)

NCT00049842 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Liver Fibrosis

Interventions

BIOLOGICAL: peginterferon alfa-2b (SCH 54031)

Sponsor

Merck Sharp & Dohme LLC